Human tau protein is one of the most advanced and accepted biomarkers for AD and tauopathies diagnosis in general [4,5,6,7], attracting increasing interest for developing anticipated and accurate molecular diagnostics [8,9,10,11]. The gene discussed is MAPT; the disease is tauopathy.